This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Breast Cancer  • Surgical Oncology  • Women's Health  • Women's Health, Other  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

I read with great interest the article by Yang et al¹ about the effect of core-needle biopsy (CNB) and fine-needle aspiration (FNA) on the measurement of tumor size in breast cancer. The authors claim that alteration of the tumor size after CNB and FNA will alter the treatment regimen. This is an interesting study that has not been done in the past in such detail.

But the important question remains how the change in size of the tumor after CNB and FNB affects the management of the patient.

England has the highest mortality and morbidity rate from breast cancer among the European countries due to lack of manpower. I had the opportunity to work as a locum tenens breast surgeon for a period of 5 weeks in a teaching hospital in England.

The treatment of breast cancer has been standardized in the whole United Kingdom. Such treatment protocol has been . . . [Full Text of this Article]

AUTHOR INFORMATION
Mohammed Badruddoja, MD, FRCS, FRACS

RELATED ARTICLE

Size of Breast Cancer Tumor After Core-Needle Biopsy and Fine-Needle Aspiration Does Not Affect Patient Treatment Plan—Reply
Jung-Hyun Yang
Arch Surg. 2005;140(10):1009.
EXTRACT | FULL TEXT